FDA Calls for Physician Action in Reporting Adverse Drug Events (ePocrates)
May 1, 2008


Patients Can Learn to do Time-Consuming Dialysis at Home (NxStage)
January 09, 2008


Prometheus Laboratories Plans IPO
December 19, 2007


IU Hospital to Expand Home Dialysis Program (NxStage)
October 23, 2007


ISTA Pharmaceuticals, Inc., Tops Deloitte's Orange County Technology Fast 50 Ranking of Fastest Growing Companies With 11,773 Percent Revenue Growth Over Five Years
October 16, 2007


Affymax® Announces Phase 3 Development Plan for Hematide™
July 16, 2007


Affymax® and Takeda Honored with the Allicense 2007 Breatkthrough Alliance Award for Their Exclusive Global Agreement for Hematide™
April 18, 2007


Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide™ for the Treatment of Anemia in Dialysis Patients
April 12, 2007


Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
April 12, 2007


Barrier Therapeutics Announces Azoline (Pramiconazole) Dose Ranging Study in Tinea Versicolor Meets Primary and Secondary Endpoints
March 27, 2007


Barrier Therapeutics Receives Regulatory Approval to Market Xolegel™ in Canada
March 8, 2007


ISTA Pharmaceuticals Announces Positive Preliminary Xibrom™ Once-daily Formulation Clinical Results From U.S. Phase III Trials
February 8, 2007


NxStage® Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One™
February 7, 2007


Affymax® Announces Completion of Common Stock Offering
December 20, 2006


eHealth, Inc. Announces Pricing of its Initial Public Offering of Common Stock
October 12, 2006


A New Look for Complex Data (Spotfire)
October 2006


Home Is Where the Healthcare Is (NxStage)
October 2006


Cerexa Reports Positive Top-Line Results for Phase 2 Clinical Trial of Ceftaroline
August 2, 2006


Quest Diagnostics to Acquire Focus Diagnostics, Inc., A World Leader in Infectious Disease Testing
May 19, 2006


NxStage Medical, Inc. Sets Price For Initial Public Offering
October 27, 2005